Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Rigetti Computing (RGTI) Stock News Today: Analysts’ 2026 Targets, Quantum Roadmap Milestones, and Why Shares Are Swinging

Rigetti Computing (RGTI) Stock News Today: Analysts’ 2026 Targets, Quantum Roadmap Milestones, and Why Shares Are Swinging

December 23, 2025 — Rigetti Computing, Inc. is back in the spotlight as quantum-computing stocks churn through sharp end‑of‑year moves. By 17:55 UTC, Rigetti shares traded around $25.24, down roughly 6% on the session after a stronger prior close, with an intraday range near $25.20–$26.82 and volume above 20 million shares.
23 December 2025
···
Procter & Gamble Stock (NYSE: PG) Today: What’s Driving Shares on Dec. 23, 2025 — Analyst Targets, Earnings Outlook, and Key Risks

Procter & Gamble Stock (NYSE: PG) Today: What’s Driving Shares on Dec. 23, 2025 — Analyst Targets, Earnings Outlook, and Key Risks

Procter & Gamble is closing out 2025 with its stock hovering near the lower half of its 52-week range—an area that’s attracting fresh attention from analysts and long-term dividend investors alike. As of December 23, 2025, PG shares are trading around $143.6, up modestly on the day after Monday’s pullback, with investors now looking ahead to two near-term catalysts: a CEO transition on January 1, 2026, and the company’s fiscal Q2 2025/26 earnings event on January 22, 2026. Barron's+1
23 December 2025
··
Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck & Co., Inc. is closing in on year-end with a rare mix of policy-driven headlines, regulatory acceleration, and pipeline catalysts that are shaping investor expectations for 2026 and beyond. From a White House-backed drug-pricing framework that offers tariff relief to drugmakers, to the FDA’s fast-track voucher program attaching itself to two Merck assets with blockbuster potential, MRK stock is being evaluated not just on quarterly numbers—but on whether Merck can extend growth beyond Keytruda while navigating intensifying U.S. drug-pricing scrutiny. Reuters+2Reuters+2
23 December 2025
··
Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Corporation stock is trading near its recent highs as 2025 winds down, with investors balancing three big forces: a shifting interest-rate outlook, improving Wall Street deal momentum, and a growing stack of analyst upgrades heading into the bank’s next earnings report.
23 December 2025
··
Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

December 23, 2025 — Eli Lilly and Company stock is holding near record territory as investors digest a fresh twist in the weight-loss drug race: the FDA has cleared Novo Nordisk’s first oral version of Wegovy, intensifying competition right as Lilly pushes its own once-daily pill candidate, orforglipron, toward a potential 2026 approval.
23 December 2025
···
Citigroup Stock (NYSE: C): Regulatory Pressure Eases, Shares Hit New 52‑Week High as Wall Street Maps the 2026 Outlook

Citigroup Stock (NYSE: C): Regulatory Pressure Eases, Shares Hit New 52‑Week High as Wall Street Maps the 2026 Outlook

Dec. 23, 2025 — Citigroup, Inc. stock is closing out 2025 with a tailwind that investors have been waiting years to see: meaningful signs that long-running regulatory overhangs are starting to lift. Coming into Tuesday’s session, Citi was already riding fresh momentum after a strong Monday rally pushed the shares to a new 52‑week high. MarketWatch
23 December 2025
·
D-Wave Quantum Inc. (QBTS) Stock Today: CES 2026 Catalyst, Analyst Price Targets, and 2026 Outlook (Dec. 23, 2025)

D-Wave Quantum Inc. (QBTS) Stock Today: CES 2026 Catalyst, Analyst Price Targets, and 2026 Outlook (Dec. 23, 2025)

D-Wave Quantum Inc. is back in the spotlight on December 23, 2025, after a headline-driven surge on Monday turned into a sharp cooldown on Tuesday—an all-too-familiar pattern for a high-volatility “pure-play” quantum computing stock. The trigger: D-Wave’s announcement that it will showcase commercial quantum technology at CES 2026, putting its pitch for real-world use cases in front of a mainstream tech audience. D-Wave Quantum+1
23 December 2025
··
CoreWeave Stock (NASDAQ: CRWV) News Today: Why Shares Are Moving, Latest AI Data-Center Catalysts, and Wall Street Forecasts (Dec. 23, 2025)

CoreWeave Stock (NASDAQ: CRWV) News Today: Why Shares Are Moving, Latest AI Data-Center Catalysts, and Wall Street Forecasts (Dec. 23, 2025)

CoreWeave, Inc. stock is sliding in Tuesday’s session after an early gap down, underscoring just how volatile the “AI infrastructure” trade has become heading into year-end. As of the latest available data timestamp, CRWV was trading around $81.93, down roughly 3.4% on the day, after opening near $82.28 and touching an intraday low around $78.77. MarketBeat
23 December 2025
GE Aerospace Stock (NYSE: GE) Hits New Highs on Jet-Engine Demand, New Orders, and 2026 Earnings Focus

GE Aerospace Stock (NYSE: GE) Hits New Highs on Jet-Engine Demand, New Orders, and 2026 Earnings Focus

GE Aerospace stock traded around $317 on December 23, 2025, pushing into fresh highs as investors continue to price in strong commercial aftermarket demand, rising engine output, and a busy news flow spanning aviation orders, manufacturing investments, and defense-related headlines. In early trading, GE changed hands near $317.16 after opening around $314.97, with an intraday range roughly $314.03–$317.58, according to market data.
23 December 2025
···
AppLovin Stock (NASDAQ: APP) Today: Dec. 23, 2025 News, Analyst Forecasts, Price Targets, and 2026 Outlook

AppLovin Stock (NASDAQ: APP) Today: Dec. 23, 2025 News, Analyst Forecasts, Price Targets, and 2026 Outlook

AppLovin Corporation stock is taking a breather on Tuesday, December 23, 2025, after a strong run that has made it one of the market’s most closely watched “AI application layer” winners of the past two years. By late morning, APP shares were trading around $713, down roughly 3% on the session, after closing near $734 on Monday. StockAnalysis+1
23 December 2025
·
1 … 702 703 704 705 706 … 891
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Constellation Energy

NASDAQ: CEG 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY

Walt Disney

NYSE: DIS 92 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 90 / 100
#5 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.